The adequacy of myocardial revascularization in patients with multivessel coronary artery disease.
暂无分享,去创建一个
[1] M. Valgimigli,et al. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients. , 2013, International journal of cardiology.
[2] J. Beckman,et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.
[3] J. Garot,et al. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization. , 2013, JACC. Cardiovascular interventions.
[4] Samin K. Sharma,et al. Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.
[5] Harlan M Krumholz,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.
[6] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[7] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[8] Michail I. Papafaklis,et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. , 2013, Journal of the American College of Cardiology.
[9] Akshay S. Desai,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.
[10] P. Pibarot,et al. The impact of complete revascularization on long-term survival is strongly dependent on age. , 2012, The Annals of thoracic surgery.
[11] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[12] Michael J Pencina,et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. , 2012, JAMA.
[13] Nikola Jagic,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.
[14] Y. Song,et al. Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era , 2012, Heart and Vessels.
[15] B. Gersh,et al. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. , 2012, Circulation. Cardiovascular interventions.
[16] K. Park,et al. Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[17] P. Serruys,et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. , 2012, Journal of the American College of Cardiology.
[18] B. Gersh,et al. Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2012, Circulation.
[19] B. Bruyne. Multivessel Disease From Reasonably Incomplete to Functionally Complete Revascularization , 2012 .
[20] R. de Caterina,et al. Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance? , 2012, Atherosclerosis.
[21] M. Bertolet,et al. Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) , 2012, Circulation. Cardiovascular interventions.
[22] Mario J. Garcia,et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, The Journal of thoracic and cardiovascular surgery.
[23] G. Stone,et al. Prognostic factors in primary and elective percutaneous coronary intervention , 2011 .
[24] M. Mack,et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[25] J. Spertus,et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.
[26] I. Édes,et al. Various clinical scenarios leading to development of the string sign of the internal thoracic artery after coronary bypass surgery: the role of competitive flow, a case series , 2012, Journal of Cardiothoracic Surgery.
[27] Laura Mauri,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[28] Min Chul Kim,et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. , 2011, International journal of cardiology.
[29] M. Mack,et al. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. , 2011, The Annals of thoracic surgery.
[30] U. Siebert,et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. , 2011, JACC. Cardiovascular interventions.
[31] M. Roffi,et al. Current concepts on coronary revascularization in diabetic patients. , 2011, European heart journal.
[32] Samin K. Sharma,et al. Impact of Incomplete Revascularization on Long-Term Mortality After Coronary Stenting , 2011, Circulation. Cardiovascular interventions.
[33] B. Gersh,et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.
[34] D. Holmes,et al. Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis , 2011 .
[35] Kevin Kennedy,et al. Appropriateness of percutaneous coronary intervention. , 2011, JAMA.
[36] D. Berman,et al. Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.
[37] Uwe Siebert,et al. Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease , 2010, Circulation.
[38] William Wijns,et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. , 2010, JACC. Cardiovascular interventions.
[39] P. Serruys,et al. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). , 2010, The American journal of cardiology.
[40] H. Krumholz,et al. Putting ad hoc PCI on pause. , 2010, JAMA.
[41] G. Sangiorgi,et al. Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.
[42] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .
[43] Uwe Siebert,et al. Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .
[44] L. Wallentin,et al. Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.
[45] N. Curzen,et al. Coronary revascularisation in chronic kidney disease. Part II: acute coronary syndromes. , 2010, Journal of renal care.
[46] N. Curzen,et al. Coronary revascularisation in chronic kidney disease. Part 1: stable coronary artery disease. , 2010, Journal of renal care.
[47] P. Serruys,et al. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. , 2010, JACC. Cardiovascular interventions.
[48] W. Wijns,et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. , 2010, JACC. Cardiovascular interventions.
[49] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[50] I. Ford,et al. Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease , 2009, Circulation.
[51] J. Ornato,et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[52] G. Sangiorgi,et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.
[53] F. Mohr,et al. Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.
[54] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.
[55] P. Kolh,et al. Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. , 2009, European heart journal.
[56] Sunil V. Rao,et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.
[57] E. Paolasso,et al. Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up. , 2009, Journal of interventional cardiology.
[58] Ying-xin Zhao,et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[59] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[60] Christopher M O'Connor,et al. Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.
[61] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.
[62] Alice Jacobs,et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. , 2009, JACC. Cardiovascular interventions.
[63] Grace A Lin,et al. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. , 2008, JAMA.
[64] K. Dimopoulos,et al. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug‐eluting stents , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[65] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[66] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.
[67] O. Penn,et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. , 2007, The Annals of thoracic surgery.
[68] Bari Investigators. The final 10-year follow-up results from the BARI randomized trial. , 2007 .
[69] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[70] Deepak L. Bhatt,et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? , 2007, Journal of the American College of Cardiology.
[71] Robert M. Minutello,et al. Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry). , 2007, The American journal of cardiology.
[72] P. Serruys,et al. Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention , 2006, Circulation.
[73] R. de Caterina,et al. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. , 2006, Journal of the American College of Cardiology.
[74] Samin K. Sharma,et al. Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.
[75] Wen Cheng,et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. , 2005, The Journal of thoracic and cardiovascular surgery.
[76] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[77] J. Beckman,et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.
[78] G. Beller,et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. , 2003, Journal of the American College of Cardiology.
[79] A. Collins,et al. Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes , 2002, Circulation.
[80] M. Ward,et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. , 2002, Journal of the American College of Cardiology.
[81] L. Shaw,et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.
[82] H. Schaff,et al. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). , 2002, Journal of the American College of Cardiology.
[83] P. Serruys,et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. , 2002, Journal of the American College of Cardiology.
[84] T. Bowker,et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. , 2001, The American journal of cardiology.
[85] M. Gotsman,et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. , 1997, Journal of the American College of Cardiology.
[86] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[87] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.
[88] Z. Bloomgarden,et al. Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.
[89] B. Gersh,et al. Effect of Completeness of Revascularization on Long‐term Outcome of Patients With Three‐Vessel Disease Undergoing Coronary Artery Bypass Surgery: A Report From the Coronary Artery Surgery Study (CASS) Registry , 1992, Circulation.
[90] B. Brent,et al. Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.
[91] C. Berry,et al. Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. , 2013, The American journal of cardiology.
[92] Deepak L. Bhatt,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.
[93] K. Mahaffey,et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .
[94] S. Rajpathak,et al. Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[95] Takeshi Kimura,et al. Predicting Long-Term Mortality After First Coronary Revascularization , 2012 .
[96] B. Gersh. Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease , 2012 .
[97] B. Gersh,et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .
[98] Samin K. Sharma,et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.
[99] Samin K. Sharma,et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. , 2009, JACC. Cardiovascular interventions.
[100] R. de Caterina,et al. Complete myocardial revascularization: between myth and reality. , 2005, European heart journal.
[101] J. Parrillo,et al. How well does radionuclide dipyridamole stress testing detect three-vessel coronary artery disease and ischemia in the region supplied by the most stenotic vessel? , 1999, Clinical nuclear medicine.